Given our previous finding that cytoskeletal microtubule networks can regulate the efficiency of HIV infection [16], we chose two additional inhibitors—ML-141 and Y-27632—which target the Rho GTPase Cdc42 and Rho associated protein kinase (ROCK), respectively [44, 45]. Here, CDC42 is linked to HIV infectious disease.